Pharmaceutical composition for treating macular degeneration (WO2012079419)

Expert Opin Ther Pat. 2013 Feb;23(2):269-72. doi: 10.1517/13543776.2013.751972. Epub 2012 Dec 10.

Abstract

A pharmaceutical composition composed of several traditional Chinese medicines is claimed to treat age-related macular degeneration (AMD). This represents a novel and alternative therapeutic solution for wet AMD, with the potential advantage of treating both the symptoms and the underlying causes of this devastating degenerative retinal disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Choroidal Neovascularization
  • Drug Combinations
  • Drugs, Chinese Herbal / therapeutic use*
  • Humans
  • Macular Degeneration / drug therapy*
  • Macular Degeneration / pathology
  • Macular Degeneration / physiopathology
  • Patents as Topic
  • Time Factors
  • Treatment Outcome
  • Visual Acuity / drug effects

Substances

  • Drug Combinations
  • Drugs, Chinese Herbal